Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 27.96%
March 31, 2026 28.98%
December 31, 2025 -121.2%
September 30, 2025 21.73%
June 30, 2025 11.07%
March 31, 2025 35.73%
December 31, 2024 34.52%
September 30, 2024 29.25%
June 30, 2024 45.54%
March 31, 2024 22.77%
December 31, 2023 -9.50%
September 30, 2023 58.94%
June 30, 2023 40.05%
March 31, 2023 20.12%
December 31, 2022 50.99%
September 30, 2022 25.17%
June 30, 2022 40.84%
March 31, 2022 18.27%
December 31, 2021 70.86%
September 30, 2021 -12.43%
June 30, 2021 43.21%
March 31, 2021 33.55%
December 31, 2020 50.00%
September 30, 2020 42.16%
June 30, 2020 13.38%
Date Value
March 31, 2020 1.68%
December 31, 2019 34.56%
September 30, 2019 50.34%
June 30, 2019 42.69%
March 31, 2019 31.55%
December 31, 2018 64.35%
September 30, 2018 46.67%
June 30, 2018 56.47%
March 31, 2018 45.56%
December 31, 2017 44.84%
September 30, 2017 46.85%
June 30, 2017 46.39%
March 31, 2017 53.50%
December 31, 2016 38.64%
September 30, 2016 36.13%
June 30, 2016 41.91%
March 31, 2016 52.52%
December 31, 2015 32.60%
September 30, 2015 47.29%
June 30, 2015 72.56%
March 31, 2015 56.10%
December 31, 2014 43.72%
September 30, 2014 51.12%
June 30, 2014 57.50%
March 31, 2014 50.38%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
MedMira, Inc. -26.66%
VentriPoint Diagnostics Ltd. -258.1%
Theralase Technologies, Inc. 21.12%
Profound Medical Corp. 78.41%
VVT Med, Inc. 45.51%

Gross Profit Margin (Quarterly) Related Metrics